Table 1 Clinicopathological characteristics of cohort. Fisher’s exact test and Chi-square test (as appropriate) were used to generate P-values
Characteristic | No. | ColXα1 Positive N (%) | P-value |
|---|---|---|---|
No. of patients | 164 | 62.8% | |
Age (year) | 164 | ||
< 65 | 99 | 57 (57.5%) | 0.10 |
≥ 65 | 65 | 46 (71%) | |
Age (year) | |||
< 58 | 61% | 0.75 | |
≥ 58 | 64% | ||
Laterality | 164 | ||
Left | 94 | 54 (57.3%) | 0.52 |
Right | 70 | 30 (42.7%) | |
Foci | 164 | ||
Solitary | 146 | 61.6% | 0.45 |
Multifocal | 18 | 72.2% | |
LVI | 130 | ||
Pos | 97 | 62 (63.9%) | 0.005 |
Neg | 33 | 21 (63.6%) | |
Lymph node status | 120 | 0.21 | |
N0 | 64 | 30 (46.9%) | |
N1 | 42 | 26 (61.9%) | |
N2 | 8 | 4 (50.0%) | |
N3 | 6 | 5 (83.3%) | |
Clinical stage | 164 | ||
I | 52 | 61.5% | 0.34 |
II | 87 | 60.9% | |
III | 22 | 77.3% | |
IV | 3 | 33.3% | |
ColXα1 | 164 | ||
0 | 21 | – | |
1 | 40 | ||
2 | 47 | ||
3 | 56 | ||
Stroma Content | 164 | ||
0 | 30 | 15 (50%) | 0.024 |
1 | 95 | 57 (60%) | |
2 | 39 | 31 (79.5%) | |
TILs | 164 | ||
1 (Rare) | 22 | 15 (68.2%) | < 0.001 |
2 (Low density) | 113 | 82 (72.6%) | |
3 (High density) | 29 | 6 (20.7%) | |